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Taking Aim at the Cancer Threat 
r 
r 
Workers check pollution levels at a chemical dumpsite in Ohio. Concern about a link between 
chemicals and cancer has prompted a search by Humphrey Center investigators for a better 
understanding of the problem. 
A ne ighborhood resident is w a l k i n g 
across a vacant lot used as a play-
gpound by local youngsters. She 
notices puddles whose surfaces are 
aswirl w i t h unexpected colors: purples, 
yellows, greens. U p close, the puddles 
have an acrid odor. 
The w o m a n calls friends. Soon, the 
ne ighborhood is rife w i t h rumors and 
speculation. Many residents are con-
vinced the foul-smell ing l iquids are 
chemicals f r o m a nearby d u m p . 
The town's health inspector is called 
i n . She promises to get the contam-
inated water tested. A week later, the 
results are back: Yes, there are toxic 
wastes on that lot. 
The neighborhood erupts. Residents 
h o l d a succession of heated meetings. 
Some families talk of m o v i n g out. 
Others demand a cleanup of the waste. 
A t first, polit ical leaders are slow to 
respond. But residents keep u p the 
pressure. There are marches, rallies. 
Media coverage of the neighborhood's 
pl ight mounts. Finally, a breakthrough: 
The governor orders a comprehensive 
study to f ind out whether the chemicals 
are harming the residents. 
Scenarios like this have been played 
out dozens of times across the nation 
i n recent years. For many of the 
residents affected, health studies are a 
major goal. Such studies, though, 
probably can't answer questions about 
the cancer threat involved. The reason, 
according to H u m p h r e y Center inves-
tigator John Groopman, Ph.D., is the 
inherent l imits of the statistical tools 
used by epidemiologists, medicine's 
detectives. 
continued on page 3. 
The Laser in 
Cancer Surgery: 
Major New 
Applications 
W h e n Geza J. Jako, M.D. , sets out to 
remove a t u m o r f r o m a patient's 
larynx, he doesn't pick up a scalpel. 
What he does instead is this: 
Looking deeply into the patient's 
throat through a special instrument 
called a laryngoscope, he carefully 
focuses on a specific p o r t i o n of the 
tumor, and then presses a button. 
That but ton activates a beam f r o m a 
carbon dioxide laser. Almost instan-
taneously, a small puff of smoke 
appears, signaling that the target area 
of the t u m o r has been vaporized. 
Thereupon, Dr. Jako shifts his focus 
slightly and prepares to fire the next 
carefully targeted laser burst. 
This type of procedure, once the 
province of science fiction, has n o w 
become routine i n treating laryngeal 
tumors. A n d m u c h of the credit 
belongs to Dr. Jako, because it was he, 
along w i t h H u m p h r e y Center colleague 
M . Stuart Strong, M.D. , w h o pioneered 
adaptation of the laser for use i n 
treating such tumors. 
Dr. Jako, a native of Hungary, 
received his medical degree f r o m 
the Semmelweis University i n 
Budapest. After the H u n -
garian revolt of 1956, he 
came to Boston. 
Whi le training as 
an otolaryngolo-
gist at Harvard, 
continued on 
page 2. 
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BEHIND THE SCENES 
People & Research 
It can't fly faster than a speeding 
bullet. It's not more p o w e r f u l than a 
locomotive. But the fluorescent-
activated cell sorter (FACS) does have 
one amazing capability: It can sort 
cells w i t h astonishing speed. 
A n advanced FACS recently was 
put into operation at the H u m p h r e y 
Center. According to Elizabeth R. 
Simons, Ph.D., a professor of bio-
chemistry and overseer of the device, 
it works like this: 
Tiny drops of l iquid, each containing 
a single cell, are dropped out of what 
amounts to a miniscule faucet. Each 
drop is given an electrical charge. 
Meanwhile , users of the device " label " 
some of the cells — for example, all 
the tumor cells i n a mixture of normal 
and cancerous cells — w i t h a fluores-
cent compound. 
"The FACS has a laser that essen-
tially acts as a detector for fluores-
cence," says Dr. Simons. " W h e n it 
strikes a fluorescent cell, it activates 
an electromagnet. The magnet then 
deflects the fluorescent cells into 
a different container f r o m the n o n -
fluorescent ones." 
The FACS, w h i c h processes up to 
2,500 cells per second, can help cancer 
investigators i n a great number of 
ways, says Dr. Simons. For example, if 
they want to k n o w h o w rapidly 
leukemia is spreading i n a lab animal, 
they can process the animal's b lood 
cells t h r o u g h the device. Even if there 
are hundreds of mi l l ions of cells, the 
FACS allows the cancer's spread to be 
gauged w i t h i n a matter of hours. • 
L A S E R I N C A N C E R 
Continued from page 1. 
Dr. Jako continued to nurture an 
interest i n medical technology. I n the 
early '60s, for example, he developed 
a new type of endoscope and other 
instruments that permit ted the use of 
microsurgery — that is, surgery done 
w i t h the aid of a low-power micro-
scope — i n the larynx. Then, his focus 
turned to the laser. 
The m i d '60s weren't an auspicious 
t ime to be experimenting w i t h medical 
uses of the laser. "Other laboratories 
had already experimented w i t h using 
the laser to treat cancer, and it was 
reported that the laser scattered t u m o r 
cells beyond the original site," recalls 
Dr. Jako. "Those reports got into the 
newspapers, w h i c h made the atmos-
phere k i n d of di f f icul t . " 
The scientist's lab experiments, 
though, convinced h i m that a type of 
laser different f r o m those used i n 
those original experiments w o u l d do 
the job. He f o u n d a supporter i n Dr. 
Strong, head of the Department of 
Otolaryngology at Boston University 
School of Medicine. Dr. Strong invi ted 
Dr. Jako, then at Massachusetts Eye and 
Ear Inf irmary, to j o i n his department. 
The pair embarked on further 
experiments. Finally, by 1971, they 
were ready to try the technique o n a 
cancer patient. 
" I t was a patient w h o already had a 
large t u m o r and was going to have his 
larynx removed anyway," recalls Dr. 
Jako. " H e gave his permission for us 
to use the laser pr ior to the laryngec-
t o m y . " 
W i t h Dr. Strong heading the surgical 
team, they per formed the procedure. 
That and succeeding operations con-
f i rmed that the laser can be very 
effective i n treating certain types of 
tumors. 
One reason the laser works so wel l , 
says Dr. Jako, is that it leaves no 
blood, so that the surgeon, especially 
w h e n using an operating microscope, 
has an excellent v iew of the t u m o r 
site. (Experienced surgeons can see 
bits of t u m o r made up of as few as 
100 to 200 cells.) A second is that 
there is no physical contact w i t h the 
tumor, and hence no risk of cancer 
cells being scattered beyond the site. 
A t h i r d is that the laser totally destroys 
the cells it strikes. 
" K n o w i n g what we k n o w now, 1 
th ink cancer is one of the diseases that 
is most amenable to laser surgery," 
says Dr. Jako, w h o besides being on 
the Boston University School of M e d i -
cine faculty maintains a practice i n 
Melrose, Mass. 
Today, the laser is used to operate 
on many tumors besides those of the 
larynx. Cancers of the skin, uterus and 
cervix, along w i t h brain tumors, are 
especially frequent targets. But Dr. 
Jako, a member of the presidentially 
appointed National Cancer Advisory 
Board, believes that the laser's promise 
has just begun to be realized. For one 
thing, he notes, surgeons are starting 
to use the laser to track d o w n hard-to-
locate offshoots of tumors. 
Cancer cells, explains Dr. Jako, differ 
in color and consistency f rom n o r m a l 
cells, and also in the way they're 
vaporized by the laser. A n d today, he 
adds, experienced surgeons are learn-
ing to identify those differences d u r i n g 
the course of surgery. 
W h y does this matter? "Most tumors 
do not make a neat border w i t h 
normal tissue," explains Dr. Jako. 
"They have t iny branches, called 
processes, that penetrate into normal 
areas. As we develop this approach, 
surgeons are f inding that they can 
fo l low a tumor process the way a 
miner fol lows a vein of coal." 
continued on page 4. 
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T A K I N G A I M A T T H E C A N C E R 
T H R E A T 
continued from page 1. 
These tools, says Dr. Groopman, an 
assistant professor of toxicology, are 
very useful w h e n a large group of 
people have been exposed to a sus-
pected cancer-causing agent over a 
long per iod of time. It was relatively 
simple to p inpoint a l ink between 
smoking and lung cancer. But w h e n 
groups are small, and exposure times 
brief or indeterminate, it's very hard to 
reach definit ive conclusions about 
cancer risks. 
N o w , though. Dr. Groopman and 
his associates are w o r k i n g on a 
technique that could revolutionize the 
task of p r o b i n g the health effects of 
toxic chemicals. 
The key to the technique is to 
identify connections between chemicals 
and D N A , the substance that makes 
u p our genes. "Most cancer-causing 
agents can't cause the disease unless 
they f o r m linkages w i t h your D N A , " 
explains Dr. Groopman. " I f an agent 
enters your body but fails to connect 
w i t h your D N A , it may do other bad 
things to y o u but it almost certainly 
w o n ' t cause cancer." 
W h e n a chemical does l ink up w i t h 
D N A , the resulting combination is 
called a D N A adduct. By injecting 
chemicals into rodents, the investi-
gators have created a group of natural 
substances called antibodies that seek 
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out and attach themselves to adducts. 
The investigators have already pro-
duced antibodies to a wide range of 
chemicals, and they continue to expand 
their targets. One chemical they're 
n o w w o r k i n g w i t h , for example, is 
ethylene d ibromide (EDB) — the 
pesticide whose discovery i n baked 
goods and other products t w o years 
ago touched off a national furor. For 
the technique to be usable on a mass 
scale, though, it has to w o r k i n sub-
stances like b lood or urine, w h i c h are 
readily obtainable f r o m large groups 
of people. 
The technique isn't yet ready for 
widespread use. More tests are needed 
to prove that it works. However , even 
w h e n ful ly tested it still w o n ' t answer 
the question. D i d this chemical cause 
cancer? F inding an adduct only means 
that the potential for creating tumors 
is there, not that a tumor is inevitable. 
Still, the technique may help to 
penetrate the mystery that surrounds 
the question of h o w toxic chemicals 
affect us. "Right now, we have no way 
of k n o w i n g whether toxic chemicals 
really represent a serious cancer risk," 
notes Groopman. " O u r approach won' t 
resolve that issue, but it w i l l provide 
some hard evidence to use i n deciding 
what to do about these environmental 
hazards."n 
C A N C E R N O T E S 
C A N C E R N O T E : The rate of stomach 
cancer, a h ighly lethal f o r m of the 
disease, has dropped by more than 40 
percent i n the Uni ted States over the 
past 25 years. Experts believe changes 
i n diet are responsible. 
C A N C E R N O T E : Coughing, w h i c h 
sometimes brings u p sputum con-
taining b lood, is the most c o m m o n 
early sign of l u n g cancer. The second 
most c o m m o n sign is a persistent ache 
i n the chest. 
C A N C E R N O T E : L u n g cancer, w h i c h 
affects more than 100,000 people 
annually and is the largest cause of 
cancer deaths, is the most preventable 
f o r m of the disease. The lung-cancer 
rate could be cut by 80 percent or 
more if American smokers dropped 
the habit. 
QUESTIONS. . . 
Answer to question on back panel. 
A . The recent National Academy of 
Sciences' report o n diet and cancer 
singled out cruciferous vegetables (so 
called because of their cross-like 
patterns) as especially effective i n 
protecting those w h o eat them f r o m 
cancer. 
One possible reason is the certain 
natural chemicals these vegetables 
contain. These chemicals seem to st im-
ulate the body to attack and break 
d o w n various cancer-causing sub-
stances. 
Whi le the evidence that cruciferous 
vegetables help prevent cancer is 
strong, that doesn't mean y o u should 
avoid other vegetables. A l l vegetables 
contain vitamins and minerals that 
may help prevent cancer. A balanced 
diet that is h igh i n grain products and 
vegetables and l o w i n foods like butter 
and fatty meats appears to be the best 
dietary approach to cancer prevention. 
Q . Why is leukemia the most common 
form of cancer in young children? 
A. Leukemia, or cancer of the whi te 
b lood cells, affects about 22,000 people 
a year, roughly 2,500 of them children. 
Kids, though, are pr ime targets for one 
particular type of the disease, called 
acute lymphocytic leukemia. I n fact, 
they account for vir tual ly all the cases 
of that disease. 
The explanation lies i n one of 
cancer's key features: the fact that it 
tends to affect the most rapidly 
g r o w i n g cells i n the body. Since the 
whi te cells called lymphocytes are 
g r o w i n g fast i n y o u n g children, these 
cells more readily become cancerous 
than others. I n older children, 
meanwhile , the bone cells are g r o w i n g 
fast, w h i c h is w h y teenagers tend to 
be more prone to bone cancer than 
are other age groups. • 
C A N C E R N O T E : A breast l u m p does 
not necessarily mean cancer. Roughly 
four-fifths of the breast lumps biopsied 
t u r n out to be benign. 
C A N C E R N O T E : C h i l d h o o d cancers 
tend to gro w more rapidly than those 
in adults, but the overall cure rate is 
higher. The current rate is estimated to 
be 80 percent or more. 
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Continued from page 2. 
Other new uses of the laser, says 
Dr. Jako, may grow out of the 
marriage of the device w i t h innovative 
diagnostic technologies: the sophisti-
cated new f o r m of x-ray called the CT 
(computerized tomography) scan; 
magnetic resonance imaging, i n w h i c h 
t iny magnetic signals f r o m i n d i v i d u a l 
cells are used to distinguish diseased 
f r o m healthy tissue; and ultrasound, i n 
w h i c h high-frequency sound waves 
help to map the shape and location of 
tumors. 
Such technologies may lead to 
accurate pictures of tumors that u p 
u n t i l recently were too small even to 
locate. This i n t u r n may spur progress 
i n dealing w i t h the frustrating prob lem 
of metastatic tumors. 
These tumors, w h i c h grow u p w h e n 
cells f r o m the original t u m o r break off 
and settle i n new sites, are often too 
small to be treated surgically. The new 
methods of diagnosis, however, may 
permit surgeons to operate on at least 
some metastatic tumors : those of 100 
m i l l i o n cells or more. 
"Once y o u had your three-dimen-
sional diagnostic picture," explains Dr. 
Jako, " y o u w o u l d go i n there w i t h the 
laser and remove these tumors. I n fact, 
you could probably use a computerized 
approach to help y o u plan exactly 
h o w to direct the laser so y o u could 
be sure to remove most of the cancer-
ous cells." After that, radiation and 
chemotherapy could be used to attack 
the remnants of the tumor . 
These and other n e w techniques, 
emphasizes Dr. Jako, are still i n the 
formative stages. Once ready for 
general use, though, they w i l l offer 
bright promise for i m p r o v i n g cancer 
cure rates. • 
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Why are cauliflower, Brussels 
sprouts, cabbage and broccoli 
considered especially good 
sources of protection against 
cancer { 
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